“Will apply”….”if” approved then they can sell a whopping 200k vials.
Nader professed to “will apply” in US, Mexico, UK, Canada, Spain and Italy. The reason he never “does” apply is that the data doesn’t show statistical significance. Please cite Nader Pourhasen’s own quote.
Now he’s yapping about India, another convenient pivot while Phillipines and Brazil are allegedly awaiting info.
Let’s see the Cytodyn promise list over the last 14 months:
- bring on world-renowned oncologist, Dr Pestell. At the time, touted as the savior and Nader awarded millions of bonus shares. End result- Nader keeps shares, Pestell keeps 25+ million shares, Pestell fired and counter-sued Nader and Cytodyn. Discovery will be interesting. TNMBC on severe delay!
-HIV BLA- failure!! FDA won’t file application and Nader continues to change reasoning. What was supposed to be “two weeks” to correct will be more than one year. $87M in milestone payments forfeited thus far because of that! Blame put on CRO- Nader hired CRO-
- uplist- Fail!
- EUA for Covid in USA: Fail and no EUA
- EUA in UK- Fail and didn’t even apply. CEO uses semantics to say “requested”
- EUA in Mexico after 25 patient trial- Fail! No EUA
- Alleged talks with Spain and Italy- Fail- nothing allowed
- shareholder lawsuits for unjust enrichment- Fail! Nader forced to settle
- NASH - TWO (2) patients so far!
- GvHD- scrapped after being touted as groundbreaking
- CURE for HIV in the bone marrow: uh, ok! FAIL.
- “No dilution”- Fail! Toxic lending agreement with unregistered financier (Fife) has exposed shareholders to dilution!
-triple digit stock: LOL, where do we begin
So now, we “going to apply” in Phillipines and then pivot to Brazil and India. Apparently, resident experts feel their FDA’s are less corrupt. Any empirical data to support either hypothesis?
Payments due to Samsung continue to build and the company as collateralized itself as assurance. Desperation causes bad decisions in hindsight.
$400+ million in debt per the Cytodyn filings.
($400,000,000) Debt
+ $0 Revenue
—————————————
$(400,000,000)
Generally that leads to insolvency. Chapter 11!!
Place your bets on the company’s track record thus far!
Grip
Market Data 
Markets 
AI
